Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status

BACKGROUNDS: Mutations in the isocitrate dehydrogenase (IDH)1 gene are favourable prognostic factors in newly diagnosed diffuse gliomas, whereas it remains controversial in the recurrent glioblastoma setting. METHODS: A total of 171 patients with newly diagnosed glioblastoma, either ‘primary’ gliobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabei, Yusuke, Kobayashi, Keiichi, Saito, Kuniaki, Shimizu, Saki, Suzuki, Kaori, Sasaki, Nobuyoshi, Shiokawa, Yoshiaki, Nagane, Motoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767982/
https://www.ncbi.nlm.nih.gov/pubmed/32888020
http://dx.doi.org/10.1093/jjco/hyaa162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767982/
https://www.ncbi.nlm.nih.gov/pubmed/32888020
http://dx.doi.org/10.1093/jjco/hyaa162

Ejemplares similares